يحاول ذهب - حر
Dr. Reddy's Misses Q1 Estimates as US Generics Biz Drags
July 24, 2025
|Mint Ahmedabad
Dr. Reddy's Laboratories Plans to Launch Weight-Loss Drug Semaglutide in 87 Countries Next Year
Dr. Reddy's Laboratories Ltd.'s US generics business slumped in the June quarter as it faced price erosion in key products like gRevlimid used to treat cancer.
US generics revenue declined 11% year-on-year and 4% sequentially to ₹3,412 crore in the first quarter of FY26, according to earnings announced on Wednesday. The business accounts for 40%, the highest among all segments, of its top line.
The base business remains stable despite the price erosion, the company's management said in a post-earnings press conference.
هذه القصة من طبعة July 24, 2025 من Mint Ahmedabad.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Ahmedabad
Mint Ahmedabad
Instant grocery delivery is going luxe to stand out
Blinkit joins the race as it expands to ozone-washed fruits and artisanal breads to cheese
2 mins
October 03, 2025
Mint Ahmedabad
OpenAI valuation soars to $500 billion
OpenAI has completed a deal to help employees sell shares in the company at a $500 billion valuation, propelling the ChatGPT owner past Elon Musk’s SpaceX to become the world’s largest startup.
1 mins
October 03, 2025
Mint Ahmedabad
Auto parts cos grow abroad, following Motherson model
Companies scout for global opportunities in forgings, castings, interiors and electronics
3 mins
October 03, 2025
Mint Ahmedabad
Hackers extort executives after claiming Oracle apps breach
Executives and technology departments at large organizations are being extorted by a notorious ransomware group that claims to have stolen their data from a suite of popular Oracle Corp. applications.
1 min
October 03, 2025
Mint Ahmedabad
WHY INDIA IS SEEKING A NEW SUNRISE IN JAPAN
India missed out on Japanese investment in its initial post-reform years. That could change now
7 mins
October 03, 2025
Mint Ahmedabad
'IT sector growth subdued in FY26'
The Indian IT sector is experiencing subdued growth, with industry guidance and recent results pointing towards a muted outlook for FY26, though a recovery in FY27 is possible with recovery in key export markets and adoption of new technology.
1 min
October 03, 2025
Mint Ahmedabad
Tata Sons should not be compelled to go public
With its stock-listing deadline having passed, suspense hangs over the future of its ownership status. It’s time for a rethink of the RBI rule that pushed Tata’s holding company into this spot
2 mins
October 03, 2025
Mint Ahmedabad
Temasek joins race to snap up stake in Romsons Group
Minority stake set to value the medical device manufacturer at about ₹1,500 crore
2 mins
October 03, 2025
Mint Ahmedabad
Nuvama's MF entry receives Sebi nod
Financial services company Nuvama Wealth Management Ltd has secured approval from markets regulator Securities and Exchange Board of India (Sebi) to set up its proposed mutual fund business.
1 min
October 03, 2025
Mint Ahmedabad
Hexaware faces $500 million patent lawsuit
relating to Hexaware’s application modernization services,” read Natsoft’s complaint.
3 mins
October 03, 2025
Listen
Translate
Change font size